Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-07-24

Clinical Trial Update: Renal Denervation in Patients With Advanced Heart Failure [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating renal denervation in patients with advanced heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bursa Postgraduate Hospital | Conditions: Heart Failure | Phase 3 | Status: WITHDRAWN